組織診断は疾患の生物学的背景を理解するために、特定の組織サンプルを分析および評価することです。これらは、がんや炎症性疾患などの特定の医学的問題を検出するために使用され、悪性腫瘍の正確な種類と程度を示し、考えられる原因の特定と治療法の選択に役立ちます。組織診断は非常に正確で低コストであり、コア生検や開腹生検など、さまざまな手順を使用して行うことができます。これらの診断は現在、免疫組織化学 (IHC)、in situハイブリダイゼーション (ISH)、デジタル病理学、特殊標識などの最新技術を使用して行われています。患者の転帰に影響を与える疾患の洞察と要因は、組織診断によって捕捉されます。組織は、一般に、個別の診断と治療を提供します。サンプルの大部分は、さまざまな手順で収集された組織断片で構成されています。小さな生検や手術中に抽出された巨大な標本がその例です。市場の成長を牽引するその他の重要な要因は、医療費の増加と組織診断の技術開発です。
目次
Contents
1. Executive Summary
2. Global Tissue Diagnostics Market
1. Product Overview
2. Market Definition
3. Segmentation
4. Assumptions and Acronyms
3. Research Methodology
1. Research Objectives
2. Primary Research
3. Secondary Research
4. Forecast Model
5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
1. Growth Drivers
2. Restraints
3. Opportunity
4. Trends
7. Correlation & Regression Analysis
1. Correlation Matrix
2. Regression Matrix
8. Recent Development, Policies & Regulatory Ladscape
9. Risk Analysis
1. Demand Risk Analysis
2. Supply Risk Analysis
10. Global Tissue Diagnostics Market Analysis
1. Porters Five Forces
1. Threat of New Entrants
2. Bargaining Power of Suppliers
3. Threat of Substitutes
4. Rivalry
2. PEST Analysis
1. Political
2. Economic
3. Social
4. Technological
11. Global Tissue Diagnostics Market
1. Market Size & forecast, 2020A-2030F
1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Global Tissue Diagnostics Market: Market Segmenation
1. By Regions
1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
3. Asia-Pacific: (China, India, Japan, South Korea, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
2. By Product: Market Share (2020-2030F)
1. Instruments, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
2. Reagents and Consumables, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
3. By Technology: Market Share (2020-2030F)
1. Immunohistochemistry , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
2. In-Situ Hybridization, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
3. Digital Pathology & Workflow Management, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
4. By Diseases: Market Share (2020-2030F)
1. Breast cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
2. Prostate cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
3. Gastric cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
4. Other cancers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
5. By End-User: Market Share (2020-2030F)
1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
2. Pharmaceutical Companies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
3. Contract Research Organizations, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
4. Research Laboratories, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile
1. Abbott Laboratories
1. Company Overview
2. Company Total Revenue (Financials)
3. Market Potential
4. Global Presence
5. Key Performance Indicators
6. SWOT Analysis
7. Product Launch
2. Agilent Technologies Inc.
3. BioGenex Laboratories
4. Cancer Genetics Inc.
5. Danaher Corporation
6. Hoffmann-La Roche Ltd
7. Genomic Health Inc.
8. Merck KGaA
9. Thermo Fisher Scientific.
10. Bio Rad
11. Biomeriux
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
